Nanocyte’s proprietary platform, enedAI, integrates deep learning, nanoparticle engineering, payload biology, target tissue context, and toxicity-aware optimization to design targeted therapeutic nanoparticles with greater precision from the start.
AI-guided nanoparticle design for targeted medicines.
A unified engine for generating, ranking, and advancing nanoparticle systems built around ensuring a medicine gets where it needs to go, safely.
Payload-aware
Therapeutic payloads are evaluated in the context of their delivery requirements, helping identify nanoparticle systems suited to their chemical and biological behavior.
Tissue-specific
Target tissue and cellular context guide candidate design, supporting nanoparticles engineered for more precise therapeutic delivery.
Toxicity-aware
Safety risk is modeled from the earliest stages of design, allowing candidates to be ranked not only by delivery potential, but by their likelihood of becoming viable therapeutic systems.
Self-improving
Experimental results feed back into the platform, improving future predictions and turning each design cycle into a stronger foundation for the next.
